ELAN vs. TEVA, GMAB, SMMT, ITCI, VTRS, MRNA, RDY, PCVX, SRPT, and ASND
Should you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Viatris (VTRS), Moderna (MRNA), Dr. Reddy's Laboratories (RDY), Vaxcyte (PCVX), Sarepta Therapeutics (SRPT), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry.
Elanco Animal Health vs.
Teva Pharmaceutical Industries (NYSE:TEVA) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
Teva Pharmaceutical Industries received 1190 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 67.87% of users gave Teva Pharmaceutical Industries an outperform vote while only 54.65% of users gave Elanco Animal Health an outperform vote.
54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by insiders. Comparatively, 0.6% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Elanco Animal Health has a net margin of 4.60% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Elanco Animal Health's return on equity.
Teva Pharmaceutical Industries currently has a consensus target price of $23.57, suggesting a potential upside of 47.23%. Elanco Animal Health has a consensus target price of $15.83, suggesting a potential upside of 39.75%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, equities research analysts plainly believe Teva Pharmaceutical Industries is more favorable than Elanco Animal Health.
In the previous week, Elanco Animal Health had 26 more articles in the media than Teva Pharmaceutical Industries. MarketBeat recorded 51 mentions for Elanco Animal Health and 25 mentions for Teva Pharmaceutical Industries. Teva Pharmaceutical Industries' average media sentiment score of 0.93 beat Elanco Animal Health's score of 0.06 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the media.
Teva Pharmaceutical Industries has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500.
Elanco Animal Health has lower revenue, but higher earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.
Summary
Teva Pharmaceutical Industries and Elanco Animal Health tied by winning 9 of the 18 factors compared between the two stocks.
Get Elanco Animal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Elanco Animal Health Competitors List
Related Companies and Tools
This page (NYSE:ELAN) was last updated on 3/3/2025 by MarketBeat.com Staff
